Kamada (KMDA) Net Income Growth (1y) (2013 - 2026)
Kamada (KMDA) Net Income Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn | -14.93% |
| 10 | Kamada | 399.49 Mn | 326.34 Mn | 19.12 Mn | 4.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.24% |
| Dec 31, 2025 | -6.46% |
| Sep 30, 2025 | 37.10% |
| Jun 30, 2025 | 66.65% |
| Mar 31, 2025 | 67.61% |
| Dec 31, 2024 | -24.71% |
| Sep 30, 2024 | 19.86% |
| Jun 30, 2024 | 144.26% |
| Mar 31, 2024 | 130,635.21% |
| Dec 31, 2023 | 171,707.07% |
| Sep 30, 2023 | 665,809.09% |
| Jun 30, 2023 | -53.79% |
| Mar 31, 2023 | -99.90% |
| Dec 31, 2022 | -41.23% |
| Sep 30, 2022 | -99.94% |
| Jun 30, 2022 | 318.46% |
| Mar 31, 2022 | -31.97% |
| Dec 31, 2021 | -99.69% |
| Sep 30, 2021 | -87.64% |
| Jun 30, 2021 | -72.90% |